F5 (FFIV) Offers FY12 Sales Growth Estimate on Call
Tweet
Share
E-mailGet Alerts FFIV Hot Sheet
Price: $384.63 +1.81%
Financial Fact:
Net income per share - diluted: 1.62
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net income per share - diluted: 1.62
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
On its Q4 conference call, an F5 (Nasdaq: FFIV) exec has said the company is targeting FY12 sales growth of about 20 percent. F5 sees capex of about $6-12 million per quarter next year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
Create E-mail Alert Related Categories
Conference Calls, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
